drugset / Trial / NCT03261596
Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana
Phase 4
Withdrawn
PATH
Ghana Health Services · collabHopeXchange Medical Center, Ghana · collabKintampo Health Research Centre, Ghana · collabNoguchi Memorial Institute for Medical Research · collabYale University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The Ghana study will hypothesize that both the multiple dose and single dose of mebendazole will achieve effective cure rates against hookworm among children and adolescents. This study is intended to be a pilot study for a planned Phase 3 registration trial of a new drug for hookworm, tribendimidine.
Timeline
- Start
- 2017-09
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mebendazole | Small molecule | 100 mg | — |
| Subject | Mebendazole | Small molecule | 500 mg | — |